Kyowa Kirin International plc.
Carlos Sesmero has over 25 years of work experience in various roles within the pharmaceutical industry. Carlos is currently the Customer Operations Director Southern Cluster at Kyowa Kirin International plc. Carlos previously held the position of Commercial Effectiveness Manager at the same company from 2017-2021. Prior to that, they worked as a Commercial Excellence Manager at Takeda Farmacéutica España from 2009-2017, where they were responsible for managing and controlling commercial activities, implementing new projects, and overseeing CRM implementation. Carlos also served as a Commercial Excellence Manager at Abbott Diabetes Care from 2008-2009, where they were responsible for CRM management and analysis of sales data. Before that, they worked as a Business Support Manager at Recordati España from 2005-2007, where they analyzed and controlled the company's CRM policy and sales activity. Carlos began their career at Sanofi-Aventis in 1995 as the Head of Sales Analysis, where they coordinated the analysis department and implemented new projects. Overall, Carlos Sesmero's work experience demonstrates their expertise in commercial effectiveness, CRM management, and sales analysis in the pharmaceutical industry.
Carlos Sesmero attended the Universidad Complutense de Madrid from 1989 to 1997, where they earned a degree in Ingeniero with a focus on Quimicas.
This person is not in any offices
Kyowa Kirin International plc.
At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a successful track record in Japan and has expanded globally. Our history of innovation is built on a strong legacy of scientific discovery and fostering collaborations that accelerate the delivery of innovative medicines to patients. Grounded in our expertise in antibody engineering, we continue to investigate new molecules with the potential to contribute to the future of healthcare and make a difference in the lives of patients. At KKI, it is our people who have helped make a real difference to our success. Working together, our employees excel in achieving results quickly and effectively, bringing diverse and unique viewpoints to the company to achieve our vision. Our passion and energy around our core values of commitment to life, innovation, integrity and teamwork help ensure that every day, each of us is focused on not just making medicines, but also making people smile. With our strong legacy and exciting future, KKI is looking for great people to join our team and support our commitment to life.